KZIA vs MSFT: Which Stock is Better?
Side-by-side comparison of Kazia Therapeutics Ltd and Microsoft Corp in 2026
KZIA
Kazia Therapeutics Ltd
$11.22
MSFT
Microsoft Corp
$422.50
Key Metrics Comparison
| Metric | KZIA | MSFT | Winner |
|---|---|---|---|
| Market Cap | $124.78M | N/A | KZIA |
| P/E Ratio | N/A | 26.32 | MSFT |
| EPS (TTM) | $N/A | $15.97 | MSFT |
| Revenue Growth | 3.1% | 0.2% | KZIA |
| Gross Margin | 100.0% | 68.6% | KZIA |
Analyze KZIA
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KZIA or MSFT a better investment?
Comparing KZIA and MSFT: Kazia Therapeutics Ltd has a market cap of $124.78M while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KZIA and MSFT?
KZIA (Kazia Therapeutics Ltd) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KZIA or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KZIA or MSFT?
KZIA has higher revenue growth at 3.1% vs 0.2% for MSFT.
Which company is more profitable: KZIA or MSFT?
Kazia Therapeutics Ltd (KZIA) has higher gross margins at 100.0% compared to 68.6% for MSFT.
Which is the larger company: KZIA or MSFT?
Kazia Therapeutics Ltd (KZIA) is larger with a market cap of $124.78M compared to N/A for MSFT.
Should I buy KZIA or MSFT in 2026?
Both KZIA and MSFT have investment merit. KZIA trades at $11.22 while MSFT trades at $422.50. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KZIA and MSFT stock?
Key differences: Market Cap ($124.78M vs N/A), P/E Ratio (N/A vs 26.3x), Revenue Growth (3.1% vs 0.2%), Gross Margin (100.0% vs 68.6%).